PTC Therapeutics Inc. (PTCT)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

46.37

-0.17%

After-hours Dec 13, 2024, 05:19 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	937.82M	698.80M	538.59M	380.77M	306.98M	264.73M	194.39M	82.70M	36.77M	22.96M	31.33M	28.78M	98.96M
Cost of Revenue	65.49M	44.68M	32.33M	18.94M	12.13M	12.67M	4.58M	117.63M	121.82M	79.84M	54.88M	-5.17M	-
Gross Profit	872.34M	654.12M	506.26M	361.82M	294.85M	252.06M	189.81M	-34.93M	-85.05M	-56.88M	-23.55M	33.95M	98.96M
Operating Income	-349.40M	-439.93M	-374.94M	-397.88M	-192.80M	-115.69M	-64.29M	-132.06M	-167.13M	-99.41M	-45.40M	-26.81M	30.58M
Interest Income	-	90.87M	86.02M	56.35M	12.49M	-	-	-	-	-	-	-	-
Pretax Income	-696.11M	-587.49M	-518.34M	-402.93M	-239.93M	-128.11M	-77.67M	-141.54M	-169.96M	-98.45M	-51.57M	-26.24M	28.60M
Net Income	-626.60M	-559.02M	-523.90M	-438.16M	-251.58M	-128.08M	-79.00M	-142.11M	-170.45M	-93.75M	-51.57M	-26.24M	30.90M
Selling & General & Admin	332.54M	326.00M	285.77M	245.16M	202.54M	153.55M	121.27M	97.13M	82.08M	44.82M	25.22M	14.62M	16.15M
Research & Development	666.56M	651.50M	540.68M	477.64M	257.45M	171.98M	117.46M	117.63M	121.82M	79.84M	54.88M	46.14M	58.68M
Other Expenses	-	116.55M	54.75M	36.89M	27.65M	129.00K	-1.28M	-1.21M	-465.00K	-213.00K	37.51K	1.78M	461.36K
Operating Expenses	1.31B	1.09B	881.21M	759.70M	487.64M	348.41M	254.11M	214.76M	203.90M	122.38M	76.72M	55.59M	68.38M
Interest Expense	129.18M	90.87M	86.02M	56.35M	12.49M	12.55M	12.09M	8.28M	2.37M	1.18M	-	-	2.44M
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	1.29B	1.14B	913.54M	778.64M	499.78M	361.08M	258.68M	214.76M	203.90M	122.38M	76.72M	55.59M	68.38M
Income Tax	-69.51M	-28.47M	5.56M	35.23M	11.65M	-29.00K	1.33M	569.00K	485.00K	-4.69M	6.21M	1.21M	-2.31M
Shares Outstanding (Basic)	74.84M	71.73M	70.47M	66.03M	58.86M	46.58M	39.11M	34.04M	33.62M	31.57M	12.82M	14.19M	14.19M
Shares Outstanding (Diluted)	74.84M	71.73M	70.47M	66.03M	58.86M	46.58M	39.18M	34.04M	33.63M	31.57M	12.83M	23.68M	23.68M
EPS (Basic)	-8.37	-7.79	-7.43	-6.64	-4.27	-2.75	-2.02	-4.17	-5.07	-2.97	-4.02	-1.85	0.00
EPS (Diluted)	-8.37	-7.79	-7.43	-6.64	-4.27	-2.75	-2.02	-4.17	-5.07	-2.97	-4.02	-1.11	0.00
EBITDA	-330.34M	-367.78M	-374.44M	-297.00M	-191.38M	-89.47M	-46.61M	-128.77M	-164.25M	-97.18M	-43.00M	-24.10M	33.45M
Depreciation & Amortization	236.59M	128.84M	71.52M	49.58M	36.06M	26.09M	17.68M	3.29M	2.88M	2.23M	2.40M	2.70M	2.87M